全  站关键词

    [Telegraph.co.uk报道]Akzo Nobel, the Dutch chemicals group, has indicated it is willing to pay around 670p a share for ICI, just days after the British chemicals group rejected its second offer.      The renewed offer is higher than the 650p Akzo offered last weekend and substantially higher than the first offer of 600p. At 670p, ICI is valued at £8bn.     It is understood talks companies will continue this week. Akzo has been given a deadline by the Takeover Panel of this Thursday to make a firm offer for ICI or walk away. The new offer will go some way towards meeting the expectations of ICI's board.      Although some leading shareholders, including Standard Life, which holds about 6pc of shares, have stated their opposition to any offer pitched below 700p, others may be willing to accept the new offer.      Akzo will face questions from some of its shareholders, notably hedge funds, that have already expressed concern that the group is in danger of overpaying in order to get ICI.      A number have lobbied for the cash it raised from selling its pharmaceutical division, Organon Biosciences, earlier this year for €11bn (£7.5bn) to be returned to them. The cash pile has sparked speculation that Akzo could itself become the target of private equity groups.      To assuage the concerns of its shareholders, Akzo has agreed a deal with Henkel, the German chemicals company, to sell it ICI's adhesives and electronics businesses in the event its bid is successful. It is understood Henkel has agreed to pay between €3.5bn (£2.3bn) and €4bn for the assets.      Akzo has long coveted ICI's paints business, Dulux, one of the most profitable in the world with strong market shares in Britain, eastern Europe and Asia.